Human PapillomaVirus (HPV) Vaccines Market set for rapid growth forecst 2019-2026| Key Players: GlaxoSmithKline plc. , Merck & Co., Inc

The global human papillomavirus vaccines market size is projected to reach USD 11.15 billion by 2026, exhibiting a CAGR of 16.3% during the forecast period. The increasing incidence of HPV associated cancers such as anal, oropharynx, and genital parts and growing demand for HPV vaccines to help reduce the infections are factors likely to bolster healthy growth of the market in the forthcoming years. Additionally, growing cases of cancer observed in females will spur demand for HPV vaccines in the foreseeable future. According to the Center for Disease Control and Prevention (CDC), higher incidence rates for vaginal, vulva and cervical cancer was recorded in the year 2018.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962

The report covers :
o Global human papillomavirus vaccines market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast time frame.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

An Overview of the Impact of COVID-19 on this Market :
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this [Market].

Please visit : https://www.fortunebusinessinsights.com/human-papillomavirus-hpv-vaccines-market-101962

Leading Players operating in the Human PapillomaVirus (HPV) Vaccines Market are :

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o GlaxoSmithKline plc.
o Merck & Co., Inc

Increasing Effectiveness and Enhancement of Vaccines to Promote Healthy Growth
The growing efficacy and improvement in vaccines for reducing the adverse effects associated with HPV infections will have a positive impact on the HPV vaccines market revenue in the forthcoming years. Furthermore, the rising focus of manufacturers towards the development of novel vaccines to immunize against HPV infections will create lucrative business opportunities in the foreseeable future. Furthermore, the growing cases of cervical cancer around the world has led to an increase in sales of HPV vaccines. For instance, Merck's Gardasil sales grew from US$ 1.7 billion in 2014 to US$ 3.2 billion in 2018. Additionally, the penetration of vaccines doses in the developing and low-income countries through the immunization programs by international organizations such as GAVI/PAHO/WHO will boost the HPV vaccines market share during the forecast period.

Mass Vaccination of Girls in Kenya to Spur Growth Opportunities
The increasing manufacturing of HPV vaccines to maintain a supply-demand balance will surge the market's revenue during the forecast period. The introduction of the HPV vaccine by the Ministry of Health of Ethiopia is predicted to facilitate the healthy growth of the market in the forthcoming year. For instance, in December 2018, the Ministry of Health of Ethiopia introduced the HPV vaccine through a school-based approach for girls of 14 years of age to immunize against cervical cancer. Furthermore, the mass vaccination of girls against HPV in Kenya will accelerate the growth of the market in the forthcoming years. For instance, in October 2018, Kenyan authorities started mass vaccination of girls against HPV. According to the World Health Organization, the East Africa region has the highest rate of cervical cancer in the world. Additionally, the increasing efforts by government authorities to provide vaccines to the underprivileged citizens will have a stellar effect on the HPV market growth. For instance, Zimbabwe introduced HPV vaccines to protect and reach 800,000 girls across the country. According to the World Cancer Research Fund, Zimbabwe has the fifth highest burden of cervical cancer in the world. Over a thousand women die from the disease in the country every year, making it the most common cause of cancer in women in the country.

Rapid Adoption of HPV Vaccines to Enable Speedy Expansion in North America
North America generated a revenue of USD 1.87 billion in 2018 and is expected to dominate the global market during the forecast period. Higher sales and value of Gardasil/Gardasil 9 along with rapid adoption of human papillomavirus vaccines across the region will boost development in the region.

Have Any Query? Ask Our Experts :
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/human-papillomavirus-hpv-vaccines-market-101962

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.